Evidence map›Paper›PMID 42129624›Full record

ArticleMolecular medicine (Cambridge, Mass.)2026

TRMT6/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression.

Zhirong Jia, Xiang Wu, Aorong Ouyang, ChengZhang, Ya Liu, Guocai Wu, Zhanghui Chen, Songyu Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhirong Jia *Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, 524000, China.
Xiang Wu *Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, 524000, China.
Aorong Ouyang *Department of Urology, Maoming People's Hospital, Maoming, 525000, China.
ChengZhangLife Science and Technology School, Lingnan Normal University, Zhanjiang, 524048, China.
Ya LiuZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, 524000, China.
Guocai WuDepartment of Hematology, Central People's Hospital of Zhanjiang, Zhanjiang, 524000, China.
Zhanghui ChenZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, 524000, China.
Songyu LiZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, 524000, China. lsyu@gdmu.edu.cn.

Funding

the Discipline Construction Fund of Zhanjiang Central Hospital, Guangdong Medical University 2022A03the Medical Scientific Research Foundation of Guangdong Province B2025041
6 · The paper itself

Abstract

Although mRNA modifications and translational regulation have been extensively studied in various cancers, the precise regulatory mechanisms governing N

Indexed as

Adaptor Proteins, Signal TransducingLeukemia, Myeloid, AcuteProtein BiosynthesisRNA, TransfertRNA MethyltransferasesAnimalsCell Line, TumorCell ProliferationCodonDisease ProgressionHumansMiceRNA MethylationAdaptor Proteins, Signal TransducingCodonRNA, TransfertRNA MethyltransferasesAMLTAB2translationTRMT6/TRMT61AtRNA modification

Identifiers

PMID42129624
PMCPMC13339324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.